127 related articles for article (PubMed ID: 2757917)
1. Prognostic factors and classification in multiple myeloma.
San Miguel JF; Sànchez J; Gonzalez M
Br J Cancer; 1989 Jan; 59(1):113-8. PubMed ID: 2757917
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic factors in IgG and micromolecular multiple myeloma. Retrospective analysis of 50 consecutive cases].
Pasqualetti P; Casale R; Colantonio D; Festuccia V; Di Lauro G; Natali G
Minerva Med; 1987 May; 78(9):603-8. PubMed ID: 3587727
[TBL] [Abstract][Full Text] [Related]
3. Classification and prognostic evaluation in multiple myeloma. A retrospective study of relationship of survivals and responses to chemotherapy to immunological types, 20 single prognostic factors, 15 clinical staging systems, and 6 morphological classifications.
Pasqualetti P; Colantonio D; Collacciani A; Casale R; Natali G
Panminerva Med; 1991; 33(2):93-110. PubMed ID: 1923560
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors affecting the survival of patients with multiple myeloma. A retrospective analysis of 86 patients.
Rapoport BL; Falkson HC; Falkson G
S Afr Med J; 1991 Jan; 79(2):65-7. PubMed ID: 1989088
[TBL] [Abstract][Full Text] [Related]
5. Staging systems for multiple myeloma: a comparison.
Gassmann W; Pralle H; Haferlach T; Pandurevic S; Graubner M; Schmitz N; Löffler H
Br J Haematol; 1985 Apr; 59(4):703-11. PubMed ID: 3986136
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the staging system proposed by Merlini, Waldenström and Jayakar for multiple myeloma.
Bettini R; Steidl L; Rapazzini P; Giardina G
Acta Haematol; 1983; 70(6):379-85. PubMed ID: 6417962
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and staging systems of multiple myeloma:
Tao ZF; Fu WJ; Yuan ZG; Wang DX; Chen YB; Hou J
Chin Med J (Engl); 2007 Oct; 120(19):1655-8. PubMed ID: 17935664
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic analysis and assessment on the clinical staging systems of multiple myeloma--a report of 206 cases].
Tao ZF; Fu WJ; Chen YB; Yuan ZG; Wang DX; Hou J
Ai Zheng; 2006 Apr; 25(4):461-4. PubMed ID: 16613681
[TBL] [Abstract][Full Text] [Related]
9. DNA-image cytometry and clinical staging systems in multiple myeloma.
Kropff M; Leo E; Steinfurth G; Esselborn H; Adler CP; Böcking A
Anticancer Res; 1994; 14(5B):2183-8. PubMed ID: 7840520
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in IgD myeloma: a study of 21 cases.
Fibbe WE; Jansen J
Scand J Haematol; 1984 Nov; 33(5):471-5. PubMed ID: 6515330
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of 2 prognostic classification systems for myeloma and examination of the correlation between initial bone marrow plasmacytosis and prognosis. A propos of a homogeneous population of 50 patients followed from diagnosis to death].
Pesce A; Cassuto JP; Grisot C; Gratecos N; Bayle J; Viot G; Dujardin P
Nouv Rev Fr Hematol (1978); 1983; 25(5):311-7. PubMed ID: 6657481
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in multiple myeloma: a new staging system based on clinical and morphological features.
Pasqualetti P; Casale R; Collacciani A; Colantonio D
Eur J Cancer; 1991; 27(9):1123-6. PubMed ID: 1835621
[TBL] [Abstract][Full Text] [Related]
13. Biclonal gammopathy in multiple myeloma: a case report.
Bakta IM; Sutarka IN
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():544-8. PubMed ID: 10895208
[TBL] [Abstract][Full Text] [Related]
14. [Screening of prognostic factors and comparing of staging systems of multiple myeloma].
Li J; Wu XB; Zhou Y; Wang X; Chen JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):926-9. PubMed ID: 22931656
[TBL] [Abstract][Full Text] [Related]
15. Prognostic variables and clinical staging in multiple myeloma.
Cavo M; Galieni P; Zuffa E; Baccarani M; Gobbi M; Tura S
Blood; 1989 Oct; 74(5):1774-80. PubMed ID: 2790201
[TBL] [Abstract][Full Text] [Related]
16. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma.
Durie BG; Salmon SE; Moon TE
Blood; 1980 Mar; 55(3):364-72. PubMed ID: 7357075
[TBL] [Abstract][Full Text] [Related]
18. IgD myeloma: clinical characteristics and a new staging system based on analysis of Japanese patients.
Shimamoto Y
Cancer Detect Prev; 1995; 19(5):426-35. PubMed ID: 7585729
[TBL] [Abstract][Full Text] [Related]
19. Determination of plasma cell secreting potential as an index of maturity of myelomatous cells and a strong prognostic factor.
Symeonidis A; Kouraklis-Symeonidis A; Grouzi E; Zolota V; Melachrinou M; Kourea K; Fragopanagou E; Giannakoulas N; Seimeni U; Tiniakou M; Matsouka P; Zoumbos N
Leuk Lymphoma; 2002 Aug; 43(8):1605-12. PubMed ID: 12400603
[TBL] [Abstract][Full Text] [Related]
20. [Relation between certain parameters of renal function and prognosis in multiple myeloma].
Cengic M; Robovic Z; Rasic S; Golemac S
Med Arh; 2001; 55(4):193-5. PubMed ID: 11769440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
